MINI FUTURE LONG - RECORDATI INDUSTRIA CHIMICA E FARMA | Market Closed - Borsa Italiana 16:04:59 2024-06-14 EDT | ||
| 13.94 EUR | -5.56% |
|
| Current month | -4.71% | ||
| 1 month | -15.18% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
RECORDATI
| Date | Price | Change |
|---|---|---|
| 24-06-14 | 13.97 | -5.35% |
| 24-06-13 | 14.76 | -2.57% |
| 24-06-12 | 15.15 | +5.35% |
| 24-06-11 | 14.38 | -7.35% |
| 24-06-10 | 15.52 | -0.58% |
Real-time Borsa Italiana
Last update June 14, 2024 at 04:04 pm
More quotesStatic data
| Product type | Knock-Out with Stop Loss |
|---|---|
| Buy / Sell | CALL |
| Underlying | RECORDATI |
| Issuer | 
BNP Paribas
|
| P1IDV4 | |
| ISIN | NLBNPIT1IDV4 |
| Date issued | 2022-10-19 |
| Strike | 34.32 € |
| Maturity | 2025-12-18 (550 Days) |
| Parity | 1 : 1 |
| Emission price | - € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 19.27 € |
|---|---|
| Lowest since issue | 3.22 € |
| Spread | 0.6 € |
| Spread % | 4.19% |
Company Profile
Recordati S.p.A. specializes in the research, development, production and marketing of pharmaceutical products. Net sales break down by family of products as follows:
- pharmaceutical and OTC products (67.9%): for the treatment of viral infections, cardiovascular, dermatological, gynecological diseases, etc.;
- medicines for rare diseases (32.1%).
Net sales are distributed geographically as follows: Italy (15%), Europe (58.5%), America (17.5%), Australasia (6.2%) and Africa (2.8%).
Sector
-
Consensus: Recordati
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
48.1
EUR
Average target price
52.64
EUR
Spread / Average Target
+9.44%
- Stock Market
- Certificates
- P1IDV4 Certificat
